Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
3.100
+0.140 (4.73%)
At close: Aug 13, 2025, 4:00 PM
3.050
-0.050 (-1.63%)
After-hours: Aug 13, 2025, 7:54 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K